President Trump is set to deliver the first official State of the Union address of his second term on Tuesday evening. Claire McCaskill and John Heilemann discuss. White House accidentally releases ...

Medical device company Globus Medical (NYSE:GMED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 25.7% year on year to $826.4 million. The company’s full-year revenue ...

The biggest name left on this year's free-agent market is left-hander Framber Valdez, who is capable of transforming a team's rotation as an established ace with a long track record of postseason ...

Anyone can view a sampling of recent comments, but you must be a Times subscriber to contribute. Log in above or subscribe here. Conversations are opinions of our readers and are subject to the ...

Artificial intelligence was responsible for almost 55,000 layoffs in the U.S. in 2025, per consulting firm Challenger, Gray & Christmas. Major firms including Amazon and Salesforce cut thousands of ...

The once-promising U.S. offshore wind industry is in a precarious state. First came a series of post-COVID economic challenges that led developers to cancel or delay some projects. Then President ...

Our unique data on the currency composition of global foreign exchange reserves, COFER, track how much of the world’s reserves are held at central banks in different currencies—such as the US dollar, ...

Chicago Bears quarterback Justin Fields (1) controls the ball against the Miami Dolphins at Soldier Field in a 2022 game. | Jamie Sabau-Imagn Images The Miami Dolphins have gotten some clarity as to ...

The Thunder's two-way field-goal efficiency helped catalyze a 68-win regular season, but it stepped back significantly in the playoffs. Record and point differential separate good teams from title ...

Fully Equipped's Johnny Wunder and Jake Morrow are joined by Bryan LaRoche to discuss why numbers should not dictate the clubs you are ultimately fit into. FBI releases images of person of interest ...

Retrospective studies have found associations between the number of intratumoral immune cells and patient outcomes for specific cancers treated with targeted therapies. However, the clinical value of ...